Longfa Kou
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 25
- Nanoparticle-Based Drug Delivery 21
- Co-authors
- Qing Yao (84 shared papers)Jin Sun (18 shared papers)Zhonggui He (14 shared papers)Ruijie Chen (61 shared papers)Ying‐Zheng Zhao (21 shared papers)Yinglei Zhai (2 shared papers)Vadivel Ganapathy (17 shared papers)Helin Xu (11 shared papers)
- Journals
- Journal of Controlled Release (13 papers)Colloids and Surfaces B Biointerfaces (10 papers)Drug Delivery (9 papers)Asian Journal of Pharmaceutical Sciences (8 papers)Materials Today Bio (6 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Longfa Kou
114 papers receiving 4.5k citations
Longfa Kou's Hit Papers
Peers
Comparison fields: 5 of 134
- Biomaterials 1.2k
- Pharmaceutical Science 466
- Molecular Medicine 136
- Biomedical Engineering 1.1k
- Molecular Biology 1.5k
Countries citing papers authored by Longfa Kou
This map shows the geographic impact of Longfa Kou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longfa Kou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longfa Kou more than expected).
Fields of papers citing papers by Longfa Kou
This network shows the impact of papers produced by Longfa Kou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longfa Kou. The network helps show where Longfa Kou may publish in the future.
Co-authors
The 25 scholars most cited alongside Longfa Kou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The endocytosis and intracellular fate of nanomedicines: Implication for rational design Hit paper breakdown → | 2013 | 507 |
| 2 | 2018 | 267 | |
| 3 | 2018 | 236 | |
| 4 | 2019 | 151 | |
| 5 | 2019 | 143 | |
| 6 | 2022 | 107 | |
| 7 | 2019 | 97 | |
| 8 | 2022 | 94 | |
| 9 | 2019 | 93 | |
| 10 | 2021 | 91 | |
| 11 | 2020 | 90 | |
| 12 | 2013 | 79 | |
| 13 | 2017 | 72 | |
| 14 | 2017 | 71 | |
| 15 | 2020 | 70 | |
| 16 | 2020 | 67 | |
| 17 | 2017 | 65 | |
| 18 | 2019 | 60 | |
| 19 | 2020 | 59 | |
| 20 | 2020 | 58 |
About Longfa Kou
Longfa Kou is a scholar working on Biomaterials, Pharmaceutical Science, Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 121 papers that have together received 4.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (21 papers), Nanoplatforms for cancer theranostics (18 papers), Heme Oxygenase-1 and Carbon Monoxide (12 papers), Drug Transport and Resistance Mechanisms (12 papers), RNA Interference and Gene Delivery (9 papers), Pancreatic function and diabetes (8 papers), Neonatal Health and Biochemistry (8 papers) and Osteoarthritis Treatment and Mechanisms (8 papers). The work is most often cited by research in Biomaterials (1.2k citations), Pharmaceutical Science (466 citations), Molecular Medicine (136 citations), Biomedical Engineering (1.1k citations) and Molecular Biology (1.5k citations). Longfa Kou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qing Yao, Jin Sun, Zhonggui He, Ruijie Chen, Ying‐Zheng Zhao, Yinglei Zhai, Vadivel Ganapathy, Helin Xu, Ying Tu and Lin Zhu. Their work appears in journals such as Journal of Controlled Release, Colloids and Surfaces B Biointerfaces, Drug Delivery, Asian Journal of Pharmaceutical Sciences and Materials Today Bio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.